Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 132 articles:
HTML format
Text format



Single Articles


    May 2018
  1. HWANG GY, Baek DW, Cho HJ, Lee SJ, et al
    Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.
    Anticancer Res. 2018;38:3151-3156.
    PubMed     Text format     Abstract available


  2. KIUCHI J, Komatsu S, Kosuga T, Kubota T, et al
    Long-term Postoperative Nutritional Status Affects Prognosis Even After Infectious Complications in Gastric Cancer.
    Anticancer Res. 2018;38:3133-3138.
    PubMed     Text format     Abstract available


  3. IWABU J, Namikawa T, Tsuda S, Kitagawa H, et al
    Successful Distal Gastrectomy for Gastric Cancer with Child-Pugh Class B Alcoholic Liver Cirrhosis.
    Anticancer Res. 2018;38:3085-3087.
    PubMed     Text format     Abstract available


  4. MARUYAMA S, Furuya S, Shiraishi K, Shimizu H, et al
    Podoplanin Expression as a Prognostic Factor in Gastric Cancer.
    Anticancer Res. 2018;38:2717-2722.
    PubMed     Text format     Abstract available


  5. MONDLANE G, Ureba A, Gubanski M, Lind PA, et al
    Estimation of Risk of Normal-tissue Toxicity Following Gastric Cancer Radiotherapy with Photon- or Scanned Proton-beams.
    Anticancer Res. 2018;38:2619-2625.
    PubMed     Text format     Abstract available


    April 2018
  6. OTOWA Y, Suzuki S, Kanaji S, Harada H, et al
    Curative Gastrectomy with Perioperative Chemotherapy Improves the Survival for Unresectable Gastric Cancer.
    Anticancer Res. 2018;38:2363-2368.
    PubMed     Text format     Abstract available


  7. HARUTA Y, Nakanishi R, Jogo T, Nakashima Y, et al
    Gastric Cancer of "Crawling Type" Detected by Additional Gastrectomy After Endoscopic Submucosal Resection.
    Anticancer Res. 2018;38:2335-2338.
    PubMed     Text format     Abstract available


  8. VIRGILIO E, Balducci G, Mercantini P, Giarnieri E, et al
    Laparoscopic Intragastric Surgery for Treating Early Gastric Cancer.
    Anticancer Res. 2018;38:1911-1916.
    PubMed     Text format     Abstract available


  9. CHIU YM, Tsai CL, Kao JT, Hsieh CT, et al
    PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma.
    Anticancer Res. 2018;38:2069-2078.
    PubMed     Text format     Abstract available


  10. TSAI CL, Chiu YM, Ho TY, Hsieh CT, et al
    Gallic Acid Induces Apoptosis in Human Gastric Adenocarcinoma Cells.
    Anticancer Res. 2018;38:2057-2067.
    PubMed     Text format     Abstract available


    March 2018
  11. ARATANI K, Sakuramoto S, Chuman M, Kasuya M, et al
    Laparoscopy-assisted Distal Gastrectomy for Gastric Cancer in Elderly Patients: Surgical Outcomes and Prognosis.
    Anticancer Res. 2018;38:1721-1725.
    PubMed     Text format     Abstract available


  12. INOKUCHI M, Nakagawa M, Baogok N, Takagi Y, et al
    Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.
    Anticancer Res. 2018;38:1685-1693.
    PubMed     Text format     Abstract available


  13. IGUCHI K, Kunisaki C, Sato S, Tanaka Y, et al
    Evaluation of Optimal Lymph Node Dissection in Remnant Gastric Cancer Based on Initial Distal Gastrectomy.
    Anticancer Res. 2018;38:1677-1683.
    PubMed     Text format     Abstract available


  14. KINOSHITA K, Beppu T, Miyata T, Kuramoto K, et al
    A Case of 15-Year Recurrence-free Survival After Microwave Coagulation Therapy for Liver Metastasis from Gastric Cancer.
    Anticancer Res. 2018;38:1595-1598.
    PubMed     Text format     Abstract available


  15. HONMA R, Sakamoto N, Ishikawa A, Taniyama D, et al
    Clinicopathological and Prognostic Significance of Epithelial Gremlin1 Expression in Gastric Cancer.
    Anticancer Res. 2018;38:1419-1425.
    PubMed     Text format     Abstract available


  16. VIRGILIO E, Giarnieri E, Giovagnoli MR, Montagnini M, et al
    Gastric Cancer Cells in Peritoneal Lavage Fluid: A Systematic Review Comparing Cytological with Molecular Detection for Diagnosis of Peritoneal Metastases and Prediction of Peritoneal Recurrences.
    Anticancer Res. 2018;38:1255-1262.
    PubMed     Text format     Abstract available


    February 2018
  17. PALAJ J, Keckes S, Marek V, Dyttert D, et al
    Fibrinogen Levels Are Associated with Lymph Node Involvement and Overall Survival in Gastric Cancer Patients.
    Anticancer Res. 2018;38:1097-1104.
    PubMed     Text format     Abstract available


  18. NAKAMURA A, Matsunaga W, Gotoh A
    Autophagy Induced by Naftopidil Inhibits Apoptosis of Human Gastric Cancer Cells.
    Anticancer Res. 2018;38:803-809.
    PubMed     Text format     Abstract available


  19. VIRGILIO E, Giarnieri E, Giovagnoli MR, Montagnini M, et al
    Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
    Anticancer Res. 2018;38:613-616.
    PubMed     Text format     Abstract available


  20. CEAUSU AR, Ciolofan A, Cimpean AM, Magheti A, et al
    The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin.
    Anticancer Res. 2018;38:811-816.
    PubMed     Text format     Abstract available


    January 2018
  21. VIRGILIO E, Balducci G, Mercantini P, Giarnieri E, et al
    Utility of Nasogastric Tube for Medical and Surgical Oncology of Gastric Cancer: A Prospective Institutional Study on a New and Precious Application of an Old and Economic Device.
    Anticancer Res. 2018;38:433-439.
    PubMed     Text format     Abstract available


  22. SHIN SH, Park SS, Ju EJ, Park J, et al
    Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer.
    Anticancer Res. 2018;38:287-293.
    PubMed     Text format     Abstract available


  23. SAITO H, Kono Y, Murakami Y, Shishido Y, et al
    Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression.
    Anticancer Res. 2018;38:107-112.
    PubMed     Text format     Abstract available


  24. DOMINGUEZ C, Rosa M, George TB, Pimiento J, et al
    Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
    Anticancer Res. 2018;38:367-372.
    PubMed     Text format     Abstract available


    December 2017
  25. MASUISHI T, Kadowaki S, Kondo M, Komori A, et al
    FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis.
    Anticancer Res. 2017;37:7037-7042.
    PubMed     Text format     Abstract available


  26. FUJII H, Iihara H, Kajikawa N, Kobayashi R, et al
    Control of Nausea Based on Risk Analysis in Patients with Esophageal and Gastric Cancer Who Received Cisplatin-based Chemotherapy.
    Anticancer Res. 2017;37:6831-6837.
    PubMed     Text format     Abstract available


  27. INOKUCHI M, Higuchi K, Takagi Y, Tanioka T, et al
    Cadherin 5 Is a Significant Risk Factor for Hematogenous Recurrence and a Prognostic Factor in Locally Advanced Gastric Cancer.
    Anticancer Res. 2017;37:6807-6813.
    PubMed     Text format     Abstract available


  28. NISHI M, Batsaikhan BE, Yoshikawa K, Higashijima J, et al
    High STAT4 Expression Indicates Better Disease-free Survival in Patients with Gastric Cancer.
    Anticancer Res. 2017;37:6723-6729.
    PubMed     Text format     Abstract available


  29. ANDREOU A, Pesthy S, Struecker B, Dadras M, et al
    Incidence and Risk Factors of Symptomatic Hiatal Hernia Following Resection for Gastric and Esophageal Cancer.
    Anticancer Res. 2017;37:7031-7036.
    PubMed     Text format     Abstract available


    November 2017
  30. KANAZAWA Y, Yamada T, Fujita I, Kakinuma D, et al
    In Vitro Chemosensitivity Test for Gastric Cancer Specimens Predicts Effectiveness of Oxaliplatin and 5-Fluorouracil.
    Anticancer Res. 2017;37:6401-6405.
    PubMed     Text format     Abstract available


    October 2017
  31. VIRGILIO E, Balducci G, Mercantini P, Ferri M, et al
    Reconstruction After Distal Gastrectomy for Gastric Cancer: Billroth 2 or Roux-En-Y Procedure?
    Anticancer Res. 2017;37:5595-5602.
    PubMed     Text format     Abstract available


  32. WOLL E, Thaler J, Keil F, Gruenberger B, et al
    Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
    Anticancer Res. 2017;37:5553-5558.
    PubMed     Text format     Abstract available


  33. LEE AA, Poddar N, Hammami MB, Veerapong J, et al
    Gastric Spindle Cell Neuroendocrine Tumor Mimicking Gastrointestinal Stromal Tumor: Unique Morphology and Diagnostic Pitfall.
    Anticancer Res. 2017;37:5893-5897.
    PubMed     Text format     Abstract available


    September 2017
  34. PACHNIA D, Drop B, Dworzanska A, Kliszczewska E, et al
    Transforming Growth Factor-beta, Interleukin-10, and Serological Markers in EBV-associated Gastric Carcinoma.
    Anticancer Res. 2017;37:4853-4858.
    PubMed     Text format     Abstract available


    August 2017
  35. YIN J, Song JN, Bai ZG, Cai J, et al
    Gastric Cancer Mortality Trends in China (2006-2013) Reveal Increasing Mortality in Young Subjects.
    Anticancer Res. 2017;37:4671-4679.
    PubMed     Text format     Abstract available


  36. DONG W, Li B, Wang J, Song Y, et al
    Exploration of the Radiotherapeutic Clinical Target Volume Delineation for Gastric Cancer from Lymph Node Metastases.
    Anticancer Res. 2017;37:4629-4634.
    PubMed     Text format     Abstract available


  37. HUO X, Xiao X, Zhang S, Zhou D, et al
    Association of Intron Microsatellite Instability and Exon Mutational Profile of TP53 in Human Gastric Cancers.
    Anticancer Res. 2017;37:4507-4514.
    PubMed     Text format     Abstract available


  38. YIN J, Cui Y, Li L, Ji J, et al
    Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.
    Anticancer Res. 2017;37:4489-4497.
    PubMed     Text format     Abstract available


  39. LI L, Cui Y, Ji JF, Jiang WG, et al
    Clinical Correlation Between WISP2 and beta-Catenin in Gastric Cancer.
    Anticancer Res. 2017;37:4469-4473.
    PubMed     Text format     Abstract available


  40. JIANG A, Zhao H, Liu X, Yu M, et al
    Comparison of Different Muscle-Relaxant Anesthetics on Growth, Migration and Invasion of Gastric Cancer Cells.
    Anticancer Res. 2017;37:4371-4378.
    PubMed     Text format     Abstract available


  41. MIMATSU K, Fukino N, Ogasawara Y, Saino Y, et al
    Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery.
    Anticancer Res. 2017;37:4215-4222.
    PubMed     Text format     Abstract available


  42. VIRGILIO E, Giarnieri E, Giovagnoli MR, Montagnini M, et al
    Early Gastric Cancer Exfoliating into Gastric Lavage (GL1 EGC) Shows a More Aggressive Behavior and Poorer Survival Compared to the Non-Exfoliative Counterpart (GL0 EGC).
    Anticancer Res. 2017;37:4199-4203.
    PubMed     Text format     Abstract available


  43. LIU L, Zhao H, Sheng L, Yang P, et al
    Collision of Lymphoepithelioma-like Carcinoma with Diffuse Large B-cell Lymphoma of the Stomach: A Case Report.
    Anticancer Res. 2017;37:4569-4573.
    PubMed     Text format     Abstract available


  44. GONG Z, Mu Y, Chen J, Chu H, et al
    Expression and Significance of Cyclophilin J in Primary Gastric Adenocarcinoma.
    Anticancer Res. 2017;37:4475-4481.
    PubMed     Text format     Abstract available


    July 2017
  45. TAKIMOTO R, Kamigaki T, Okada S, Matsuda E, et al
    Efficacy of Adoptive Immune-cell Therapy in Patients with Advanced Gastric Cancer: A Retrospective Study.
    Anticancer Res. 2017;37:3947-3954.
    PubMed     Text format     Abstract available


  46. SATAKE H, Kondo M, Mizumoto M, Kotake T, et al
    Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer.
    Anticancer Res. 2017;37:3703-3710.
    PubMed     Text format     Abstract available


  47. KAITO A, Kinoshita T, Tokunaga M, Sunagawa H, et al
    Prognostic Factors and Recurrence Pattern of Far-advanced Gastric Cancer with Pathologically-positive Para-aortic Lymph Nodes.
    Anticancer Res. 2017;37:3685-3692.
    PubMed     Text format     Abstract available


  48. KASHIHARA H, Shimada M, Yoshikawa K, Higashijima J, et al
    Correlation Between Thrombospondin-1 Expression in Non-cancer Tissue and Gastric Carcinogenesis.
    Anticancer Res. 2017;37:3547-3552.
    PubMed     Text format     Abstract available


    June 2017
  49. MOON JH, Fujiwara Y, Hirao M, Imamura H, et al
    Randomized Controlled Trial of Adjuvant Chemotherapy with Fluoropyrimidines Versus Surgery-alone for Gastric Cancer.
    Anticancer Res. 2017;37:3061-3067.
    PubMed     Text format     Abstract available


  50. TOKUMOTO M, Tanaka H, Tauchi Y, Tamura T, et al
    Immunoregulatory Function of Lymphatic Endothelial Cells in Tumor-draining Lymph Nodes of Human Gastric Cancer.
    Anticancer Res. 2017;37:2875-2883.
    PubMed     Text format     Abstract available


  51. VIRGILIO E, Proietti A, D'Urso R, Cardelli P, et al
    Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability.
    Anticancer Res. 2017;37:2817-2821.
    PubMed     Text format     Abstract available


  52. ARATANI K, Komatsu S, Ichikawa D, Ohashi T, et al
    Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2017;37:3129-3135.
    PubMed     Text format     Abstract available


    May 2017
  53. KANAZAWA Y, Fujita I, Kakinuma D, Arai H, et al
    Initial Experience with Nab-Paclitaxel for Patients with Advanced Gastric Cancer: Safety and Efficacy.
    Anticancer Res. 2017;37:2715-2720.
    PubMed     Text format     Abstract available


  54. INADOMI K, Kusaba H, Matsushita Y, Tanaka R, et al
    Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer.
    Anticancer Res. 2017;37:2663-2671.
    PubMed     Text format     Abstract available


  55. DA SILVA OLIVEIRA KC, Bona AB, DA Silva FJ, Pinheiro TM, et al
    Expression of hsa-miR-9 and MYC Copy Number Variation in Hereditary Diffuse Gastric Cancer.
    Anticancer Res. 2017;37:2401-2406.
    PubMed     Text format     Abstract available


    April 2017
  56. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available


  57. KUNIZAKI M, Fukuda A, Wakata K, Tominaga T, et al
    Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Anticancer Res. 2017;37:1979-1984.
    PubMed     Text format     Abstract available


    March 2017
  58. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
    Anticancer Res. 2017;37:1343-1347.
    PubMed     Text format     Abstract available


  59. MITA K, Ito H, Ota E, Takahashi K, et al
    Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection.
    Anticancer Res. 2017;37:1329-1333.
    PubMed     Text format     Abstract available


  60. AHN SY, Kim J, Kim MA, Choi J, et al
    Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
    Anticancer Res. 2017;37:1127-1138.
    PubMed     Text format     Abstract available


  61. DAI X, Liu D, Liu M, Zhang X, et al
    Anti-metastatic Efficacy of Traditional Chinese Medicine (TCM) Ginsenoside Conjugated to a VEFGR-3 Antibody on Human Gastric Cancer in an Orthotopic Mouse Model.
    Anticancer Res. 2017;37:979-986.
    PubMed     Text format     Abstract available


    February 2017
  62. SATOH T, Kaira K, Takahashi K, Takahashi N, et al
    Prognostic Significance of the Expression of CD98 (4F2hc) in Gastric Cancer.
    Anticancer Res. 2017;37:631-636.
    PubMed     Text format     Abstract available


  63. BAUER G
    Central Signaling Elements of Intercellular Reactive Oxygen/Nitrogen Species-dependent Induction of Apoptosis in Malignant Cells.
    Anticancer Res. 2017;37:499-513.
    PubMed     Text format     Abstract available


  64. BACKMAN S, Norlen O, Eriksson B, Skogseid B, et al
    Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
    Anticancer Res. 2017;37:705-712.
    PubMed     Text format     Abstract available


  65. PROUET P, Giri S, Wiedower E, Fintel A, et al
    Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality.
    Anticancer Res. 2017;37:813-817.
    PubMed     Text format     Abstract available


    January 2017
  66. OGATA K, Yanai M, Kuriyama K, Suzuki M, et al
    Double Endoscopic Intraluminal Operation (DEILO) for Early Gastric Cancer: Outcome of Novel Procedure for Endoscopic Submucosal Dissection.
    Anticancer Res. 2017;37:343-347.
    PubMed     Text format     Abstract available


  67. SUGIYAMA K, Narita Y, Kadowaki S, Ura T, et al
    Platinum-based Doublet Chemotherapy for Advanced Gastric Cancer with Disseminated Intravascular Coagulation.
    Anticancer Res. 2017;37:309-313.
    PubMed     Text format     Abstract available


  68. JUKIC Z, Radulovic P, Stojkovic R, Mijic A, et al
    Gender Difference in Distribution of Estrogen and Androgen Receptors in Intestinal-type Gastric Cancer.
    Anticancer Res. 2017;37:197-202.
    PubMed     Text format     Abstract available


  69. KOGURE N, Yokobori T, Ogata K, Altan B, et al
    Low Expression of FBXO45 Is Associated with Gastric Cancer Progression and Poor Prognosis.
    Anticancer Res. 2017;37:191-196.
    PubMed     Text format     Abstract available


  70. LEE D, Yu EJ, Ham IH, Hur H, et al
    Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer.
    Anticancer Res. 2017;37:135-142.
    PubMed     Text format     Abstract available


    December 2016
  71. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Efficacy of Nab-Paclitaxel as Second-line Chemotherapy for Unresectable or Recurrent Gastric Cancer.
    Anticancer Res. 2016;36:6699-6703.
    PubMed     Text format     Abstract available


  72. TOIYAMA Y, Shimura T, Yasuda H, Fujikawa H, et al
    Clinical Burden of C-Reactive Protein/Albumin Ratio Before Curative Surgery for Patients with Gastric Cancer.
    Anticancer Res. 2016;36:6491-6498.
    PubMed     Text format     Abstract available


    November 2016
  73. ZHENG LC, Yang MD, Kuo CL, Lin CH, et al
    Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
    Anticancer Res. 2016;36:6031-6042.
    PubMed     Text format     Abstract available


  74. HAYASHI N, Kataoka H, Yano S, Kikuchi JI, et al
    Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer.
    Anticancer Res. 2016;36:6005-6009.
    PubMed     Text format     Abstract available


    October 2016
  75. ARIGAMI T, Uenosono Y, Ishigami S, Yanagita S, et al
    Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer.
    Anticancer Res. 2016;36:5431-5436.
    PubMed     Text format     Abstract available


  76. ALTAN B, Yokobori T, Ide M, Bai T, et al
    High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.
    Anticancer Res. 2016;36:5237-5247.
    PubMed     Text format     Abstract available


  77. YAWATA K, Osada S, Tanahashi T, Matsui S, et al
    The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer.
    Anticancer Res. 2016;36:5215-5226.
    PubMed     Text format     Abstract available


  78. LEMOINE N, Adenis A, Bouche O, Duhamel A, et al
    Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
    Anticancer Res. 2016;36:5543-5549.
    PubMed     Text format     Abstract available


  79. KNIEF J, Reddemann K, Petrova E, Herhahn T, et al
    High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction.
    Anticancer Res. 2016;36:5339-5345.
    PubMed     Text format     Abstract available


    September 2016
  80. KIM EY, Jun KH, Jung JH, Jo YS, et al
    Laparoscopic Gastrectomy Followed by Chemotherapy for Advanced Gastric Cancer Diagnosed During Pregnancy: A Case Report.
    Anticancer Res. 2016;36:4813-6.
    PubMed     Text format     Abstract available


  81. KIM DJ, Kim W
    Laparoscopy-assisted Proximal Gastrectomy with Double Tract Anastomosis Is Beneficial for Vitamin B12 and Iron Absorption.
    Anticancer Res. 2016;36:4753-8.
    PubMed     Text format     Abstract available


    August 2016
  82. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Improved Efficacy by Addition of Protein-bound Polysaccharide K to Adjuvant Chemotherapy for Advanced Gastric Cancer.
    Anticancer Res. 2016;36:4237-41.
    PubMed     Text format     Abstract available


  83. CHOU NH, Tsai CY, Tu YT, Wang KC, et al
    Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells.
    Anticancer Res. 2016;36:3983-90.
    PubMed     Text format     Abstract available


  84. ROMAN LD, Lukyanchuk R, Sablin OA, Araslanova EI, et al
    Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel(R)) in St. Petersburg.
    Anticancer Res. 2016;36:4129-38.
    PubMed     Text format     Abstract available


    June 2016
  85. KOMATSU S, Ichikawa D, Kosuga T, Okamoto K, et al
    Clinical Impact of Laparoscopy and Endoscopy Cooperative Surgery (LECS) on Gastric Submucosal Tumor After its Standardization.
    Anticancer Res. 2016;36:3041-7.
    PubMed     Text format     Abstract available


  86. YONENAGA Y, Kurosawa M, Mise M, Yamagishi M, et al
    Pancreatic-type Acinar Cell Carcinoma of the Stomach Included in Multiple Primary Carcinomas.
    Anticancer Res. 2016;36:2855-64.
    PubMed     Text format     Abstract available


    May 2016
  87. FUKUCHI M, Mochiki E, Ishiguro T, Ogura T, et al
    Prognostic Factors for Gastric Cancer with Cancer Cells in the Peritoneal Cavity.
    Anticancer Res. 2016;36:2481-5.
    PubMed     Text format     Abstract available


  88. MURAKAMI T, Zhang Y, Wang X, Hiroshima Y, et al
    Orthotopic Implantation of Intact Tumor Tissue Leads to Metastasis of OCUM-2MD3 Human Gastric Cancer in Nude Mice Visualized in Real Time by Intravital Fluorescence Imaging.
    Anticancer Res. 2016;36:2125-30.
    PubMed     Text format     Abstract available


    April 2016
  89. KIM EY, Choi HJ, Cho JB, Lee J, et al
    Totally Laparoscopic Total Gastrectomy Versus Laparoscopically Assisted Total Gastrectomy for Gastric Cancer.
    Anticancer Res. 2016;36:1999-2003.
    PubMed     Text format     Abstract available


  90. KUCERA R, Smid D, Topolcan O, Karlikova M, et al
    Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.
    Anticancer Res. 2016;36:1967-71.
    PubMed     Text format     Abstract available


  91. KAWAGUCHI T, Komatsu S, Ichikawa D, Kimura YU, et al
    Prognostic Influence of the Extent of Lymph Node Dissection and Perioperative Comorbidities in Patients with Gastric Cancer.
    Anticancer Res. 2016;36:1917-22.
    PubMed     Text format     Abstract available


  92. OHASHI T, Komatsu S, Ichikawa D, Kosuga T, et al
    Tumor Index as a Combined Indicator of Tumor Depth and Size in Gastric Cancer.
    Anticancer Res. 2016;36:1895-900.
    PubMed     Text format     Abstract available


  93. NAKASHIMA Y, Nakanishi R, Sugiyama M, Ohgaki K, et al
    Laparoscopic Resection of Gastric Cancer in a Patient with Chronic Lymphocytic Leukemia Accompanied by Neutropenia.
    Anticancer Res. 2016;36:1779-83.
    PubMed     Text format     Abstract available


  94. KOSAKA T, Akiyama H, Makino H, Kimura J, et al
    Impact of Neoadjuvant Chemotherapy Among Patients with Pancreatic Fistula After Gastrectomy for Advanced Gastric Cancer.
    Anticancer Res. 2016;36:1773-7.
    PubMed     Text format     Abstract available


  95. MAKATSORIS T, Tsamandas AC, Strimpakos A, Alexopoulou Z, et al
    HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
    Anticancer Res. 2016;36:1581-90.
    PubMed     Text format     Abstract available


  96. TANAKAYA K, Yamaguchi T, Ishikawa H, Hinoi T, et al
    Causes of Cancer Death Among First-Degree Relatives in Japanese Families with Lynch Syndrome.
    Anticancer Res. 2016;36:1985-9.
    PubMed     Text format     Abstract available


    March 2016
  97. SHAO S, Sun PH, Satherley LK, Gao X, et al
    Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.
    Anticancer Res. 2016;36:1295-303.
    PubMed     Text format     Abstract available


  98. JIA S, Cai J
    Update on Biomarkers in Development of Anti-angiogenic Drugs in Gastric Cancer.
    Anticancer Res. 2016;36:1111-8.
    PubMed     Text format     Abstract available


  99. SUN J, Ling B, Xu X, Ma R, et al
    Decreased Expression of Tumor-suppressor Gene LKB1 Correlates with Poor Prognosis in Human Gastric Cancer.
    Anticancer Res. 2016;36:869-75.
    PubMed     Text format     Abstract available


  100. ZIMMERMANN N, Lazar-Karsten P, Keck T, Billmann F, et al
    Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.
    Anticancer Res. 2016;36:921-4.
    PubMed     Text format     Abstract available


    February 2016
  101. KUBO H, Komatsu S, Ichikawa D, Kawaguchi T, et al
    Impact of Body Weight Loss on Recurrence After Curative Gastrectomy for Gastric Cancer.
    Anticancer Res. 2016;36:807-13.
    PubMed     Text format     Abstract available


    January 2016
  102. KURILOVICH S, Belkovets A, Reshetnikov O, Openko T, et al
    Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia.
    Anticancer Res. 2016;36:247-53.
    PubMed     Text format     Abstract available


  103. MIN HL, Kim J, Kim WH, Jang BG, et al
    Epigenetic Silencing of the Putative Tumor Suppressor Gene GLDC (Glycine Dehydrogenase) in Gastric Carcinoma.
    Anticancer Res. 2016;36:179-87.
    PubMed     Text format     Abstract available


  104. MASUDA GO, Yashiro M, Kitayama K, Miki Y, et al
    Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer.
    Anticancer Res. 2016;36:129-36.
    PubMed     Text format     Abstract available


    December 2015
  105. MATSUMOTO T, Matsuda D, Honma K, Aoyagi Y, et al
    One-stage Procedure for Concomitant Abdominal Aortic Aneurysm and Gastric Cancer.
    Anticancer Res. 2015;35:6909-12.
    PubMed     Text format     Abstract available


  106. ASO T, Uozaki H, Morita S, Kumagai A, et al
    Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
    Anticancer Res. 2015;35:6819-27.
    PubMed     Text format     Abstract available


  107. FUJIWARA Y, Omori T, Demura K, Miyata H, et al
    A Multidisciplinary Approach for Advanced Gastric Cancer with Paraaortic Lymph Node Metastasis.
    Anticancer Res. 2015;35:6739-45.
    PubMed     Text format     Abstract available


  108. SCHMIDT K, Moser C, Hellerbrand C, Zieker D, et al
    Targeting Fibroblast Growth Factor Receptor (FGFR) with BGJ398 in a Gastric Cancer Model.
    Anticancer Res. 2015;35:6655-65.
    PubMed     Text format     Abstract available


  109. OHYAMA M, Tsuchiya A, Kaku Y, Kanno T, et al
    Phosphatidylinositol Derivatives Induce Gastric Cancer Cell Apoptosis by Accumulating AIF and AMID in the Nucleus.
    Anticancer Res. 2015;35:6563-71.
    PubMed     Text format     Abstract available


    November 2015
  110. FUKUCHI M, Ishiguro T, Ogata K, Kimura A, et al
    Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer.
    Anticancer Res. 2015;35:6183-7.
    PubMed     Text format     Abstract available


  111. HEINZELMANN S, Bauer G
    Site-specific Effects of DUOX1-Related Peroxidase on Intercellular Apoptosis Signaling.
    Anticancer Res. 2015;35:5955-71.
    PubMed     Text format     Abstract available


  112. POTTGIESSER SJ, Heinzelmann S, Bauer G
    Intercellular HOCl-mediated Apoptosis Induction in Malignant Cells: Interplay Between NOX1-Dependent Superoxide Anion Generation and DUOX-related HOCl-generating Peroxidase Activity.
    Anticancer Res. 2015;35:5927-43.
    PubMed     Text format     Abstract available


    October 2015

  113. Laparoscopic Gastrectomy for Gastric Cancer.
    Anticancer Res. 2015;35:5709.
    PubMed     Text format    


  114. TAMURA T, Ohira M, Tanaka H, Muguruma K, et al
    Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer.
    Anticancer Res. 2015;35:5369-76.
    PubMed     Text format     Abstract available


  115. KOSAKA T, Davydova J, Ono HA, Akiyama H, et al
    Imaging and Antitumoral Effect of a Cyclo-oxygenase 2-specific Replicative Adenovirus for Small Metastatic Gastric Cancer Lesions.
    Anticancer Res. 2015;35:5201-10.
    PubMed     Text format     Abstract available


    September 2015
  116. SHOJI H, Yamada Y, Okita N, Takashima A, et al
    Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance.
    Anticancer Res. 2015;35:5055-61.
    PubMed     Text format     Abstract available


  117. JI HX, Chang WS, Tsai CW, Wang JY, et al
    Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan.
    Anticancer Res. 2015;35:4975-4981.
    PubMed     Text format     Abstract available


  118. YAMAMOTO M, Kawano H, Yamaguchi S, Egashira A, et al
    Comparison of Neoadjuvant Chemotherapy to Surgery Followed by Adjuvant Chemotherapy in Japanese Patients with Peritoneal Lavage Cytology Positive for Gastric Carcinoma.
    Anticancer Res. 2015;35:4859-63.
    PubMed     Text format     Abstract available


  119. SHIMURA T, Toiyama Y, Tanaka K, Saigusa S, et al
    Angiopoietin-like Protein 2 as a Predictor of Early Recurrence in Patients After Curative Surgery for Gastric Cancer.
    Anticancer Res. 2015;35:4633-9.
    PubMed     Text format     Abstract available


  120. NUKATSUKA M, Nakagawa F, Takechi T
    Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Anticancer Res. 2015;35:4605-15.
    PubMed     Text format     Abstract available


  121. CHROM P, Stec R, Szczylik C
    Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives.
    Anticancer Res. 2015;35:4575-83.
    PubMed     Text format     Abstract available


    July 2015
  122. TOYOKAWA T, Ohira M, Sakurai K, Kubo N, et al
    The Role of Adjuvant Chemotherapy for Patients with Stage IB Gastric Cancer.
    Anticancer Res. 2015;35:4091-7.
    PubMed     Text format     Abstract available


  123. KIM SH, Lee OJ, Kwon JL, Kim JM, et al
    Altered Expression of Yes-associated Protein and beta-Catenin in Non-neoplastic and Neoplastic Gastric Surface Epithelia.
    Anticancer Res. 2015;35:3925-31.
    PubMed     Text format     Abstract available


  124. JERNMAN J, Hagstrom J, Maenpaa H, Valimaki MJ, et al
    Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.
    Anticancer Res. 2015;35:3767-72.
    PubMed     Text format     Abstract available


    June 2015
  125. SHIDA A, Futawatari N, Fukuyama T, Ichiki Y, et al
    Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
    Anticancer Res. 2015;35:3575-9.
    PubMed     Text format     Abstract available


  126. KIM JY, Ryoo HM, Bae SH, Kang BW, et al
    Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.
    Anticancer Res. 2015;35:3531-6.
    PubMed     Text format     Abstract available


  127. OHI M, Mori K, Toiyama Y, Mohri Y, et al
    Preoperative prediction of peritoneal metastasis in gastric cancer as an indicator for neoadjuvant treatment.
    Anticancer Res. 2015;35:3511-8.
    PubMed     Text format     Abstract available


  128. KIM HS, Lee HS, Nam KH, Choi J, et al
    Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Anticancer Res. 2015;35:3501-10.
    PubMed     Text format     Abstract available


    May 2015
  129. KATSUBE T, Murayama M, Yamaguchi K, Usuda A, et al
    Additional Surgery After Non-curative Resection of ESD for Early Gastric Cancer.
    Anticancer Res. 2015;35:2969-74.
    PubMed     Text format     Abstract available


  130. CACINA C, Arikan S, Duzkoylu Y, Dogan MB, et al
    Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters.
    Anticancer Res. 2015;35:2709-13.
    PubMed     Text format     Abstract available


  131. CHOI B, Lee EJ, Park YS, Kim SM, et al
    Pentraxin-3 Silencing Suppresses Gastric Cancer-related Inflammation by Inhibiting Chemotactic Migration of Macrophages.
    Anticancer Res. 2015;35:2663-8.
    PubMed     Text format     Abstract available


    April 2015
  132. VIEIRA PC, Burbano RM, Fernandes DC, Montenegro RC, et al
    Population stratification effect on cancer susceptibility in an admixed population from Brazilian Amazon.
    Anticancer Res. 2015;35:2009-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: